Title: CA19-9/DBil: A Promising Indicator to Distinguish Between CA19-9-Elevated
Pancreatic Head-Type Autoimmune Pancreatitis and Pancreatic Head Cancer
Version: 1 Date: 08 Mar 2025
Reviewer:  Sadettin Er
Reviewer's report:
I have reviewed your article titled CA19-9/DBil: A Promising Indicator to Distinguish Between
CA19-9-Elevated Pancreatic Head-Type Autoimmune Pancreatitis and Pancreatic Head Cancer
in detail. It is certain that you provide a cutoff value for the CA19-9/DBil level and its power in
distinguishing between autoimmune pancreatitis and cancer located in the pancreatic head will
be quite impressive and guiding. I believe that the acceptance of the article in its current form
will contribute to the literature. Its important limitation can be said to be the scarcity of cases.
Title: CA19-9/DBil: A Promising Indicator to Distinguish Between CA19-9-Elevated
Pancreatic Head-Type Autoimmune Pancreatitis and Pancreatic Head Cancer
Version: 1 Date: 08 Mar 2025
Reviewer:  Sadettin Er
Reviewer's report:
I have reviewed your article titled CA19-9/DBil: A Promising Indicator to Distinguish Between
CA19-9-Elevated Pancreatic Head-Type Autoimmune Pancreatitis and Pancreatic Head Cancer
in detail. It is certain that you provide a cutoff value for the CA19-9/DBil level and its power in
distinguishing between autoimmune pancreatitis and cancer located in the pancreatic head will
be quite impressive and guiding. I believe that the acceptance of the article in its current form
will contribute to the literature. Its important limitation can be said to be the scarcity of cases.
Please review this paper.
user
Title: CA19-9/DBil: A Promising Indicator to Distinguish Between CA19-9-Elevated
Pancreatic Head-Type Autoimmune Pancreatitis and Pancreatic Head Cancer
Version: 1 Date: 08 Mar 2025
Reviewer:  Sadettin Er
Reviewer's report:
I have reviewed your article titled CA19-9/DBil: A Promising Indicator to Distinguish Between
CA19-9-Elevated Pancreatic Head-Type Autoimmune Pancreatitis and Pancreatic Head Cancer
in detail. It is certain that you provide a cutoff value for the CA19-9/DBil level and its power in
distinguishing between autoimmune pancreatitis and cancer located in the pancreatic head will
be quite impressive and guiding. I believe that the acceptance of the article in its current form
will contribute to the literature. Its important limitation can be said to be the scarcity of cases.
assistant